The drug has a list-price of $1,000 a pill, a total of $84,000 for a 12-week course of therapy. Gilead already provides a 23 percent mandated discount to government insurers.
Gilead representatives believe the concern over the drug is due to the volume of demand.
More Articles on Gastroenterology:
12 Gastroenterologist Moves & Honors
7 Gastroenterologists on Benchmarking & Colonoscopy Quality (Part 2)
AGA Supports ICD-10 Delay, Opposes Temporary SGR Fix
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
